Martin Carrasco

ORCID: 0000-0003-3420-8048
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chromatin Remodeling and Cancer
  • Cancer Mechanisms and Therapy
  • Orthopedic Surgery and Rehabilitation
  • Breast Cancer Treatment Studies
  • Mechanisms of cancer metastasis
  • Advanced Breast Cancer Therapies
  • Neural Networks and Reservoir Computing
  • Optical Network Technologies
  • Musculoskeletal synovial abnormalities and treatments
  • Protein Kinase Regulation and GTPase Signaling
  • Protein Degradation and Inhibitors
  • Endoplasmic Reticulum Stress and Disease
  • Cancer Risks and Factors
  • Animal Virus Infections Studies
  • Biochemical and Molecular Research
  • Multiple and Secondary Primary Cancers
  • Traumatic Ocular and Foreign Body Injuries
  • Photonic and Optical Devices

Universidad de Ingeniería y Tecnología
2024

Hospital Universitario Puerta de Hierro Majadahonda
2020

Southwestern Medical Center
2015

The University of Texas Southwestern Medical Center
2015

Indiana University School of Medicine
2013-2014

Indiana University
2014

Indiana University South Bend
2013

// Lynn Roy 1 , Serene J. Samyesudhas Martin Carrasco Jun Li 2 Stancy Joseph Richard Dahl 3 and Karen D. Cowden 1,4,5 Department of Biochemistry Molecular Biology, Indiana University School Medicine, South Bend, Applied Computational Mathematics Statistics, Notre Dame, Microbiology Immunology, 4 Chemistry Eck Institute for Global Health, Dame University, 5 Melvin Bren Simon Cancer Center, Indianapolis, Correspondence: email: Keywords : Ovarian cancer, transcription factor, cancer stem cells,...

10.18632/oncotarget.2247 article EN Oncotarget 2014-07-23

Abstract As one of the first identified and most commonly activated oncogenes, V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) has been a focus cancer research for many decades. Despite progress in our understanding RAS biology, significant questions remain unanswered regarding observed differences clinical outcomes between tumors harboring different KRAS mutations. In an attempt to understand these we characterized pertinent biochemical properties mutants including, nucleotide...

10.1158/1538-7445.am2015-lb-031 article EN Cancer Research 2015-08-01

Abstract In 2011, 21,880 women were diagnosed with ovarian cancer and more than 13,850 died from the disease. Unfortunately, prognosis for most is poor due to patients being local distant metastases. ARID3B, a DNA binding protein AT-rich interactive domain (ARID) family, overexpressed in late stage neuroblastoma cancer. early development, ARID3B essential as evidenced by deaths of Arid3B null embryos midgestation. The importance development its overexpression suggest potential role...

10.1158/1538-7445.tim2013-a45 article EN Cancer Research 2013-02-01
Coming Soon ...